News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
373,698 Results
Type
Article (28926)
Company Profile (330)
Press Release (344442)
Section
Business (104500)
Career Advice (231)
Deals (17254)
Drug Delivery (58)
Drug Development (65322)
Employer Resources (37)
FDA (8326)
Job Trends (7537)
News (191916)
Policy (14824)
Tag
Academia (1483)
Alliances (29139)
Alzheimer's disease (911)
Antibody-drug conjugate (ADC) (117)
Approvals (8325)
Artificial intelligence (146)
Bankruptcy (144)
Best Places to Work (6618)
Biotechnology (267)
Breast cancer (251)
Cancer (1888)
Cardiovascular disease (97)
Career advice (204)
CAR-T (133)
Cell therapy (353)
Clinical research (52750)
Collaboration (563)
Compensation (246)
COVID-19 (1245)
C-suite (138)
Data (1429)
Diabetes (125)
Diagnostics (3665)
Earnings (38390)
Events (64656)
Executive appointments (411)
FDA (8967)
Funding (494)
Gene therapy (222)
GLP-1 (399)
Government (1730)
Healthcare (10018)
Infectious disease (1311)
Inflammatory bowel disease (111)
IPO (9298)
Job creations (1306)
Job search strategy (192)
Layoffs (290)
Legal (2380)
Lung cancer (279)
Lymphoma (120)
Manufacturing (128)
Medical device (3786)
Medtech (3787)
Mergers & acquisitions (8218)
Metabolic disorders (377)
Neuroscience (1249)
NextGen: Class of 2025 (2967)
Non-profit (2089)
Northern California (1694)
Obesity (196)
Opinion (128)
Parkinson's disease (92)
Patents (113)
People (32167)
Phase I (17909)
Phase II (23835)
Phase III (16317)
Pipeline (651)
Postmarket research (1547)
Preclinical (7541)
Prostate cancer (89)
Radiopharmaceuticals (253)
Rare diseases (271)
Real estate (2118)
Regulatory (11907)
Research institute (1665)
Series A (92)
Southern California (1431)
Startups (2300)
United States (13398)
Vaccines (276)
Weight loss (114)
Date
Today (45)
Last 7 days (577)
Last 30 days (1925)
Last 365 days (24944)
2025 (3866)
2024 (25305)
2023 (28069)
2022 (34360)
2021 (35766)
2020 (30917)
2019 (23328)
2018 (17044)
2017 (19232)
2016 (17593)
2015 (20564)
2014 (15390)
2013 (11944)
2012 (12215)
2011 (12292)
2010 (11936)
Location
Africa (234)
Asia (23649)
Australia (4224)
California (3786)
Canada (1162)
China (346)
Colorado (152)
Connecticut (168)
Delaware (93)
Europe (52679)
Florida (471)
Georgia (103)
Illinois (250)
Indiana (143)
Maryland (513)
Massachusetts (2890)
Minnesota (160)
New Jersey (999)
New York (1093)
North Carolina (567)
Northern California (1694)
Ohio (113)
Pennsylvania (658)
South America (333)
Southern California (1431)
Texas (537)
Washington State (372)
373,698 Results for "cancer therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Pfizer Continues Cancer Rally as Adectris Label Expands to Non-Hodgkin Lymphomas
Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate cancer, while recent readouts also position the pharma as a strong contender in colorectal cancer and bladder cancer.
February 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
February 10, 2025
·
4 min read
Pipeline
Exelixis Looks to Next-Gen Cancer Drug as Cabometyx Underwhelms Again
Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma and head-and-neck cancer, with several readouts slated for the second half of 2025.
February 19, 2025
·
2 min read
·
Tristan Manalac
Cancer
Arcus Challenges Merck in Kidney Cancer with Early Data
Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, according to analysts at Truist Securities.
February 18, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Amgen, Ideaya Call It Quits on Cancer Combo
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in MTAP-null advanced non-small cell lung cancer.
February 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
Lung Cancer Therapeutics Market Size to Reach USD 71.30 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
Cancer Therapeutics and Biotherapeutics Market Size to Expand USD 440.59 Bn by 2034
February 26, 2025
·
1 min read
Press Releases
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
February 20, 2025
·
4 min read
Press Releases
Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics
February 5, 2025
·
5 min read
1 of 37,370
Next
